| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/25/2010 | CA2734646A1 Hot-melt extrusion of modified release multi-particulates |
| 02/25/2010 | CA2734459A1 Anthelmintic compositions |
| 02/25/2010 | CA2734442A1 Methods and compositions for oral administration of proteins |
| 02/25/2010 | CA2733902A1 Human notch3 based fusion proteins as decoy inhibitors of notch3 signaling |
| 02/25/2010 | CA2733514A1 Formulation for oral administration of proteins |
| 02/25/2010 | CA2731184A1 Polymeric benzyl carbonate-derivatives |
| 02/24/2010 | EP2157096A1 Amphipathic molecule, molecular aggregate comprising the amphipathic molecule, and use of the molecular aggregate |
| 02/24/2010 | EP2156848A1 Low-molecule drug-containing nanoparticle having sustained release negatively charged group |
| 02/24/2010 | EP2156845A1 Combined vaccines comprising hepatitis B surface antigen and other antigens |
| 02/24/2010 | EP2156840A2 Use of mometasone furoate for treating airway passage and lung diseases |
| 02/24/2010 | EP2156838A1 Method for producing pharmaceutical tablet |
| 02/24/2010 | EP2156832A1 Pharmaceutical composition |
| 02/24/2010 | EP2156824A1 Composition of solifenacin or salt thereof for use in solid formulation |
| 02/24/2010 | EP2155791A1 Humanized and chimeric anti-trop-2 antibodies that mediate cancer cell cytotoxicity |
| 02/24/2010 | EP2155782A2 Mhc peptide complexes and uses thereof in infectious diseases |
| 02/24/2010 | EP2155781A1 Labelled adrenomedullin derivatives and their use for imaging and therapy. |
| 02/24/2010 | EP2155258A1 Improved processes for making hydrazides |
| 02/24/2010 | EP2155257A1 Methods of reducing nephrotoxicity in subjects administered with nucleoside |
| 02/24/2010 | EP2155256A1 Novel antibody and use in diagnosis and therapy of arthropathies |
| 02/24/2010 | EP2155255A2 Compositions that include a hydrophobic compound and a polyamino acid conjugate |
| 02/24/2010 | EP2155254A2 Polymers conjugated with platinum drugs |
| 02/24/2010 | EP2155253A2 Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs |
| 02/24/2010 | EP2155252A1 Injectable polymer-lipid blend for localized drug delivery |
| 02/24/2010 | EP2155250A1 Carbohydrate-containing pan cancer marker |
| 02/24/2010 | EP2155164A1 Self-precipitating pharmaceutical formulations for the modified release of active principle |
| 02/24/2010 | EP2155163A1 Composition for injection including propofol and method of preparing the same |
| 02/24/2010 | EP2155162A1 Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same |
| 02/24/2010 | EP1869185B1 Conjugate comprising p21 protein for the treatment of cancer |
| 02/24/2010 | EP1789057B1 Neuroprotective effect of solubilized udca in focal ischemic model |
| 02/24/2010 | EP1725267B1 Enzyme-prodrug therapy for prosthetic joint repair |
| 02/24/2010 | EP1501774B9 Polyunsaturated linear aldehydes and their derivatives with anti-radical activity |
| 02/24/2010 | EP1007084B1 Immunogenic lhrh compositions and methods relating thereto |
| 02/24/2010 | EP0837696B1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 02/24/2010 | CN101657216A Novel base for dry solid dispersion, solid dispersion containing the base, and composition containing the dispersion |
| 02/24/2010 | CN101654479A Mammalian receptor proteins, agents, and methods relating thereto |
| 02/24/2010 | CN101653613A Application and method of hydroxypropyl -sulfonylurea-beta-cyclodextrin in chloramphenicol eye drops |
| 02/24/2010 | CN101653612A Adriamycin nano preparation prepared from albumin-glucan and application thereof |
| 02/24/2010 | CN101653611A Albumin-adriamycin nano preparation, preparing method and application thereof |
| 02/24/2010 | CN101653610A Emulsifiable paste matrix of elemene transdermal preparation as well as preparation method and application thereof |
| 02/24/2010 | CN101653609A Octenyl succinate starch with colon targeting controlled release function and preparation method thereof |
| 02/24/2010 | CN101653424A 高药物载荷片剂 High drug load tablets |
| 02/24/2010 | CN101653421A Compositions comprising pectin and ascorbic acid |
| 02/24/2010 | CN100591721C Poloxamer emulsion preparations |
| 02/24/2010 | CN100591358C Method for preparing highly water-soluble cydiodine |
| 02/24/2010 | CN100591357C Crosslinkable skin care adhesive |
| 02/24/2010 | CN100591356C Compositions containing nicorandil, preparation method and use |
| 02/24/2010 | CN100591333C Stable eye lotion containing latanoprost as active ingredient |
| 02/24/2010 | CN100591329C Montelukast granule formulation |
| 02/23/2010 | USRE41151 Comprising a modified NSAID, wherein the NSAID is covalently attached either directly or through a linker molecule to a sulfur-containing functional group containing an optionally substituted hydrocarbyl moiety; nonsteroidal anti-inflammatory drugs; side-effect reduction |
| 02/23/2010 | USRE41148 Comprising an immediate-release component and an enteric delayed-release component; amphetamine aspartate and sulfate salts, dextroamphetamine saccharate or sulfate salts; FDA listed patent for Adderall XR 10 |
| 02/23/2010 | US7668603 Medical composition employing nanostructures |
| 02/23/2010 | US7667057 Cosmetic composition comprising a complex of cyclodextrin and vitamin F |
| 02/23/2010 | US7667015 Genetic engineering; induce immunology response; biodrug as anticarcinogenic agents, for pancreatic cancer |
| 02/23/2010 | US7666979 Methods for preparing multivalent constructs for therapeutic and diagnostic applications and methods of preparing the same |
| 02/23/2010 | US7666914 Topical preparation and method for transdermal delivery and localization of therapeutic agents |
| 02/23/2010 | US7666876 Buprenorphine formulations for intranasal delivery |
| 02/23/2010 | US7666844 Dry mouldable drug formulation |
| 02/23/2010 | US7666446 Oral formulation for delivery of poorly absorbed drugs |
| 02/23/2010 | US7666444 Organic amine salt of closantel; administered with carrier and optionally macrocyclic lactone; bioavailability, blood concentration; veterinary medicine |
| 02/23/2010 | US7666439 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
| 02/23/2010 | US7666430 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 02/23/2010 | US7666424 Directed against a target antigen, cell culture to express, code the protein, for treating cancer |
| 02/23/2010 | US7666413 For subcutaneous administration; hypertonic; useful for preventing self-association of reconstituted lyophilized formulations |
| 02/23/2010 | US7666410 incorporates a composition containing alumina to which various functional materials containing particular moieties may be adsorbed onto the alumina and used as desired such as pharmaceuticals, xenobiotics, anti-microbial agents, anti-viral agents |
| 02/23/2010 | US7666409 Soy sauce comprising 3.55% or less by weight of sodium, 0.5-4.2% by weight of potassium, and 0.05-10% by weight of a food material having an antihypertensive effect, wherein remaining portion of liquid seasoning is adapted by incorporation of a substance having nitrogen content of 1.6% or more |
| 02/23/2010 | US7666407 Inhibiting dental diseases caused by bacteria; foods, oral hygiene products |
| 02/23/2010 | US7666398 Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby |
| 02/23/2010 | CA2473312C Non-gelatin capsule shell formulation comprising iota-carrageenan and kappa-carrageenan |
| 02/23/2010 | CA2470492C Aqueous compositions containing metronidazole |
| 02/23/2010 | CA2403566C Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 02/23/2010 | CA2387710C Preparation containing active ingredients and/or auxiliary agents with a controlled release of these substances and the use and production of the same |
| 02/23/2010 | CA2378945C Multi-dose erythropoietin formulations |
| 02/23/2010 | CA2378880C Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 02/23/2010 | CA2353448C Improvements in or relating to powders |
| 02/23/2010 | CA2154698C Therapeutic inhibitor of vascular smooth muscle cells |
| 02/18/2010 | WO2010019718A2 Carrier nanoparticles and related compositions, methods and systems |
| 02/18/2010 | WO2010019239A2 Pharmaceutical composition and administrations thereof |
| 02/18/2010 | WO2010019233A1 Multi-arm polymeric alkanoate conjugates |
| 02/18/2010 | WO2010019059A1 Veterinary preparation |
| 02/18/2010 | WO2010018866A1 Stabilized pharmaceutical composition |
| 02/18/2010 | WO2010018855A1 Drug sustained release agent, adsorbent, functional food, mask, and adsorptive sheet |
| 02/18/2010 | WO2010018777A1 Odor-controlling method |
| 02/18/2010 | WO2010018723A1 Liquid indigo carmine preparation |
| 02/18/2010 | WO2010018614A1 Hydrophilic amino acid-containing preparation having improved taste |
| 02/18/2010 | WO2010018339A1 Colorless antiseptic solution for skin use |
| 02/18/2010 | WO2010018324A1 Polysaccharides functionalised by tryptophan derivatives |
| 02/18/2010 | WO2010018286A1 Ph-sensitive dendritic polymeric micelles |
| 02/18/2010 | WO2010018223A1 Encapsulation of lipophilic or amphiphilic therapeutic agents in nano-emulsions |
| 02/18/2010 | WO2010018159A1 Pharmaceutical compositions |
| 02/18/2010 | WO2010018003A2 Carrier system for biological agents containing organosilicon compounds and uses thereof |
| 02/18/2010 | WO2010017614A1 Mucoadherents compositions and their use |
| 02/18/2010 | WO2009150651A4 Injectable hydrogel forming chitosan mixtures |
| 02/18/2010 | WO2009140341A3 Atorvastatin compositions |
| 02/18/2010 | WO2009134076A3 Combined composition for controlled-release of angiotensin-ii-receptor blocker and hmg-coa reductase inhibitor |
| 02/18/2010 | WO2009129509A3 Methods and compositions for treating post-operative pain comprising a local anesthetic |
| 02/18/2010 | WO2009129453A3 Clonidine formulation in a polyorthoester carrier |
| 02/18/2010 | WO2009129437A3 Methods and compositions for treating post-operative pain comprising clonidine |
| 02/18/2010 | WO2009126302A3 Stabilized oleosome preparations and methods of making them |
| 02/18/2010 | WO2009126301A3 Controlled release of active agents from oleosomes |
| 02/18/2010 | WO2009117616A3 Carbon nanotube compositions and methods of use thereof |